MRI Study of Spinal Fluid Flow in Normal Pressure Hydrocephalus
Examines MRI scans of fluid flow around the brain in normal pressure hydrocephalus.
Key facts
- Who runs it
- Chungnam National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Analysis of Cerebrospinal Fluid Dynamics in Normal Pressure Hydrocephalus
- Status
- Recruiting
- People taking part
- 22 people, planned
- Started
- 11 Sept 2025
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Cerebrospinal fluid drainge
- Record updated
- 21 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with signs of normal pressure hydrocephalus, a build-up of brain fluid. It studies fluid flow on MRI before and after fluid drainage.
- Age
- 55 Years to 80 Years
- Sex
- All sexes can join.
- Disease stage
- Walking problems plus at least one of: memory or thinking problems, or bladder problems. Evans' ratio ≥ 0.3 on brain MRI, a measure of enlarged brain fluid spaces.
Main reasons for not taking part
- Lower spine problems that prevent fluid drainage
- Reasons a lumbar puncture cannot be done, such as infection at the site, suspected high brain pressure, platelet count < 40,000/µL, or a bleeding disorder
- Other nerve diseases that cause walking problems, such as Parkinson's disease or similar syndromes
- Cannot have MRI, for example due to a pacemaker, implanted defibrillator or other device not safe for MRI
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients presenting with clinical symptoms consistent with normal pressure hydrocephalus (presence of gait disturbance accompanied by at least one of the following: cognitive impairment or urinary dysfunction)
- Evans' ratio ≥ 0.3 on brain MRI
Who cannot take part
- Coexisting neurological disorders that can also cause gait disturbance, such as Parkinson's disease, atypical parkinsonian syndromes, or vascular parkinsonism
- Contraindications to MRI (e.g., presence of cardiac pacemakers, implantable defibrillators, or other non-MRI-compatible implantable medical devices)
- Contraindications to lumbar puncture and CSF drainage (e.g., local infection at the puncture site, suspected elevated intracranial pressure, platelet count < 40,000/µL, or coagulopathy)
- Patients who cannot undergo CSF drainage due to structural abnormalities of the lumbar spine
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate whether phase-contrast magnetic resonance imaging (MRI)-based cerebrospinal fluid (CSF) flow dynamics can improve the diagnosis and prognostic assessment of normal pressure hydrocephalus (NPH). In addition, the study investigates how changes in CSF flow parameters before and after CSF diversion procedures are associated with clinical improvement.
The group in the trial
- Cerebrospinal fluid draingeTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Analysis of Cerebrospinal Fluid Dynamics in Patients With Normal Pressure Hydrocephalus Using Magnetic Resonance Imaging
- Plain-language title
- MRI Study of Spinal Fluid Flow in Normal Pressure HydrocephalusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07831044, who can take part
- Record updated
- 21 September 2026